New drug hope for lung cancer sufferers
March 29th, 2011 - 12:26 pm ICT by IANSLondon, March 29 (IANS) Lung cancer sufferers, who have stopped responding to chemotherapy, could benefit from a new drug which is undergoing tests.
The experimental drug, known as LY2181308, aims to stop the growth of deadly tumours by blocking a protein that allows them to develop.
If the trial - being carried out at Oxford Radcliffe Hospitals with teams from Oxford University and Cancer Research UK - is successful it could lead to new treatment for patients with advanced lung cancer and give them longer to live.
The disease, which is contracted by 30,000 people a year in Britain alone, often goes undiagnosed until it has become advanced and currently fewer than 10 percent of sufferers survive for five years after diagnosis, the Telegraph reports.
Denis Talbot at The University of Oxford, said: “It’s greatly encouraging that we’re able to take this new experimental drug to treat lung cancer into further development. We hope that it may increase survival rates for lung cancer patients.”
Lung cancer sufferers are usually given a drug called docetaxel if their disease continues to develop after they have the standard chemotherapy treatment. The experimental drug will undergo an international trial soon.
- Targeted cancer drug more effective after first-line treatment - Feb 28, 2011
- New technique offers fresh hope to lung cancer sufferers - Mar 22, 2011
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- Chemo-Vandetanib combo effective for lung cancer treatment: Study - Jun 06, 2010
- New therapy shows promising result for HER2-positive metastatic disease - Oct 09, 2010
- Cuba launches world's first lung cancer retardant - Sep 07, 2011
- Indian-origin scientist's finding offers hope for advanced cancer patients - Apr 06, 2011
- Electric shocks soften up cancer cells for treatment - Dec 07, 2010
- Daily aspirin cuts bowel cancer death risk - Apr 26, 2012
- Chemo-radiotherapy prevents bladder cancer recurrences - Oct 26, 2010
- New drug may fight ovarian cancer - Jun 07, 2010
- Many keep smoking even after cancer diagnosis - Jan 23, 2012
- This jab could revolutionise cancer treatment - Apr 15, 2011
- Novel combo therapy may benefit head, neck cancer patients - May 31, 2009
- Gene set shows which patients benefit from chemo after surgery - Sep 08, 2010
Tags: aims, cancer research uk, cancer sufferers, chemotherapy, chemotherapy treatment, denis talbot, diagnosis, docetaxel, experimental drug, further development, london march, lung cancer, lung cancer patients, oxford radcliffe hospitals, oxford university, protein, survival rates for lung cancer, telegraph reports, tumours, university of oxford